Robert Clement Jr, MD
Family Medicine · Orlando, FLNPI 1487645396
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 658 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,833 and has fallen 73.5% since, to $1,018 in 2025. Among family medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 658 payments — averaging $22.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$2K
- AbbVie$2K
- Lilly USA, LLC$1K
- Pfizer$918
- GSK$906
- plus $6K from 35 others
What the payments were for
- Food & beverage$14,664100%
- Education$590%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 104 | $2,177 |
| AstraZeneca | 70 | $2,004 |
| AbbVie(2 entities) | 57 | $1,612 |
| Lilly USA, LLC | 70 | $1,158 |
| Pfizer | 55 | $918 |
| GSK | 28 | $906 |
| Johnson & Johnson | 24 | $879 |
| Amgen | 33 | $776 |
| Boehringer Ingelheim | 35 | $705 |
| Merck | 44 | $612 |
| Sanofi-aventis U.S. LLC | 24 | $444 |
| Exact Sciences | 17 | $348 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $310 |
| Novartis | 6 | $293 |
| Bayer | 11 | $249 |
| Amarin Pharma, Inc. | 10 | $151 |
| Clarus Therapeutics Inc. | 1 | $125 |
| Ironshore Pharmaceuticals Inc. | 1 | $110 |
| Phathom Pharmaceuticals, Inc. | 5 | $110 |
| Eisai Inc. | 4 | $96 |
| Dynavax Technologies Corporation | 4 | $78 |
| Jazz Pharmaceuticals Inc. | 5 | $71 |
| Gilead | 4 | $64 |
| Phadia US Inc. | 3 | $57 |
| Sanofi Pasteur Inc. | 4 | $51 |
| Dexcom, Inc. | 3 | $45 |
| Teva Pharmaceuticals USA, Inc. | 3 | $40 |
| Endo Pharmaceuticals Inc. | 2 | $39 |
| Dermira, Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $33 |
| Boston Scientific | 1 | $33 |
| Upsher-smith Laboratories LLC | 1 | $30 |
| Noven Therapeutics, LLC | 1 | $26 |
| Amneal Pharmaceuticals LLC | 2 | $26 |
| Antares Pharma, Inc. | 1 | $23 |
| Bausch Health US, LLC | 1 | $22 |
| Genentech USA, Inc. | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
| Vistapharm, Inc. | 1 | $12 |
| Abbott | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,723 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 76 | $100,460 |
| EliquisApixaban | 84 | $81,853 |
| JardianceEmpagliflozin | 65 | $64,250 |
| FarxigaDapagliflozin Propanediol | 39 | $46,761 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 49 | $45,660 |
| OzempicSemaglutide | 35 | $44,312 |
| Tresiba Flextouch U-200Insulin Degludec | 20 | $24,088 |
| Xigduo XrDapaglifloz Propaned/Metformin | 22 | $21,019 |
| XareltoRivaroxaban | 13 | $17,339 |
| JanuviaSitagliptin Phosphate | 13 | $13,484 |
| Jentadueto XrLinagliptin/Metformin Hcl | 11 | $5,813 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 86 | $3,706 |
| Atorvastatin Calcium | 432 | $3,681 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $3,191 |
| Rosuvastatin Calcium | 177 | $3,099 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $1,158 | $100,46076 claims |
| PfizerEliquis | $918 | $81,85384 claims |
| Boehringer IngelheimJardiance, Jentadueto Xr | $705 | $70,06476 claims |
| MerckJanumet Xr, Januvia | $612 | $59,14462 claims |
| AstraZenecaFarxiga | $2,004 | $46,76139 claims |
| Novo NordiskOzempic | $2,177 | $44,31235 claims |
| Johnson & JohnsonXarelto | $879 | $17,33913 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $26 | $1,758175 claims |
| AbbVieSynthroid | $1,612 | $1,06118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Orlando
- Richard LappOrlando$702K
- Asim RahmanOrlando$124K
- Arilda MargjoniOrlando$71K
- Rafael PineroOrlando$61K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.